ABI-007 With Carboplatin as First-Line Therapy in Patients With Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Carcinoma

Clinical trial NCT00407407 · TERMINATED

Trial details

NCT number: NCT00407407
Sponsor: Celgene
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Fallopian Tube Neoplasms Peritoneal Neoplasms Ovarian Neoplasms

Start date: 2006-11-01
Primary completion: 2008-02-01
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.